I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
The ECHELON-2 Trial: 5-year results of a randomized, phase ..:
Horwitz, S
;
O'Connor, O. A
;
Pro, B
...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.annonc.2021.12.002. , 2021
Link:
https://hal.univ-lille.fr/hal-04247540
RT Journal T1
The ECHELON-2 Trial: 5-year results of a randomized, phase 3 study of brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma
UL https://suche.suub.uni-bremen.de/peid=base-ftccsdartic:oai:HAL:hal-04247540v1&Exemplar=1&LAN=DE A1 Horwitz, S A1 O'Connor, O. A A1 Pro, B A1 Trümper, L A1 Iyer, S A1 Advani, R A1 Bartlett, N. L A1 Christensen, J. H A1 Morschhauser, Franck A1 Domingo-Domenech, E A1 Rossi, G A1 Kim, W. S A1 Feldman, T A1 Menne, T A1 Belada, D A1 Illés, Á A1 Tobinai, K A1 Tsukasaki, K A1 Yeh, S. P A1 Shustov, A A1 Hüttmann, A A1 Savage, K. J A1 Yuen, S A1 Zinzani, P. L A1 Miao, H A1 Bunn, V A1 Fenton, K A1 Fanale, M A1 Puhlmann, M A1 Illidge, T PB HAL CCSD; Elsevier YR 2021 K1 brentuximab vedotin K1 CHOP K1 frontline treatment K1 peripheral T-cell lymphoma K1 randomized clinical trial K1 overall survival K1 [SDV]Life Sciences [q-bio] JF info:eu-repo/semantics/altIdentifier/doi/10.1016/j.annonc.2021.12.002 LK http://dx.doi.org/https://hal.univ-lille.fr/hal-04247540 DO https://hal.univ-lille.fr/hal-04247540 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)